• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    agilon health Appoints Two New Executives to Leadership Team

    2/14/22 8:30:00 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care
    Get the next $AGL alert in real time by email

    Heidi Hittner and Claire Mulhearn to serve as Chief Experience Officer and Chief Communications and Public Affairs Officer, respectively

    agilon health, inc. (NYSE:AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced the appointment of Heidi Hittner and Claire Mulhearn as Chief Experience Officer and Chief Communications and Public Affairs Officer, respectively. Both Hittner and Mulhearn will become members of agilon health's Executive Leadership team, reporting to Steve Sell, Chief Executive Officer.

    In their new roles, Hittner will be responsible for the company's in-market organic growth strategy, patient and provider experience, and quality and experience measures including HEDIS, STARS and Net Promoter Score (NPS) reporting. Mulhearn will be responsible for corporate communications, branding and patient engagement, public policy, and corporate responsibility, as well as she will co-lead environmental, social & governance (ESG).

    "These two senior appointments reflect our vision to transform healthcare at the community level," said Steve Sell, Chief Executive Officer. "Heidi and Claire are seasoned health care executives with deep expertise which will greatly benefit agilon health, our physician partners and senior patients."

    Hittner has more than 25 years' experience in patient experience, growth strategies and quality. Hittner joined agilon heath in January 2019 as Senior Vice President, Provider Strategies and Growth. Prior to joining agilon health, Hittner led the development of physician services and strategies which fueled success in value-based care Fresenius Medical Care North America. Prior to Fresenius, Hittner spent over a decade at Concentra, where she led operations nationally and the success of Concentra's NPS transformation is highlighted in Fred Reichheld's book "The Ultimate Question 2.0". Hittner earned her B.S. and master's degree at Loma Linda University.

    Mulhearn has more than 20 years communications, marketing and advocacy experience. Mulhearn joined agilon health in August 2021 as Vice President and Head of Corporate Communications and Brand. Prior to joining agilon health, Mulhearn held senior external affairs roles at Merck including head of communications for Merck's expansive human health portfolio and R&D engine, communications lead for blockbuster brand KEYTRUDA, and strategic lead for critical patient engagement and heath equity efforts. Mulhearn is a member of the Page Society, Fierce Life Sciences advisory board member, and previous PR Week 40 Under 40 honoree. Mulhearn earned her B.A. from the Annenberg School of Communication at the University of Southern California (USC).

    In addition, the company announced that Lisa Dombro, Chief Experience and Innovation Officer, will leave the organization to assume a leadership opportunity with another company. Lisa joined agilon health in 2017 and prior to assuming her current role, she held various senior executive positions, including Senior Vice President and Chief of Communications in Planning and Strategic Development and Senior Vice President, Innovation and Growth.

    About agilon health

    agilon health is transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients. Through our partnerships and our platform, agilon is leading the nation in creating the system we need – one built on the value of care, not the volume of fees. We honor the independence of local physicians and serve as their partners so they can be the doctors they trained to be. agilon provides the capital, data, payor relationships, executive experience and contract support that allow physician groups to take on the risk of total care for their most vulnerable patients. The result: healthier communities, and doctors who can devote the right amount of time with the patients who need it most. With rapidly growing appeal, agilon is scaled to grow and is here to help our nation's best independent physician groups have a sustained, thriving future. Together, we are reinventing primary care. For more information about agilon health, visit www.agilonhealth.com and connect with us on Twitter, Instagram, LinkedIn and YouTube.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220214005116/en/

    Get the next $AGL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AGL

    DatePrice TargetRatingAnalyst
    4/25/2025$5.00Neutral → Buy
    Citigroup
    4/8/2025$8.50Mkt Perform → Outperform
    Bernstein
    1/10/2025$1.75 → $2.25Sell → Neutral
    Citigroup
    1/10/2025Hold
    Needham
    12/16/2024Neutral
    Macquarie
    12/11/2024$2.50Mkt Perform
    Bernstein
    11/11/2024Mkt Outperform → Mkt Perform
    JMP Securities
    11/8/2024Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $AGL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • agilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference

      agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the Bernstein 41st Annual Strategic Decisions Conference including a fireside chat presentation on Wednesday, May 28 at 4:30 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the "Events & Presentations" section of agilon health's investor relations website at https://investors.agilonhealth.com. Replays will be available for on-demand listening shortly after the completion of the presentation. About agilon health agilon health is the trusted partner empowering

      5/19/25 4:04:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • agilon health to Participate in BofA Securities 2025 Health Care Conference

      agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the BofA Securities 2025 Health Care Conference including a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the "Events & Presentations" section of agilon health's investor relations website at https://investors.agilonhealth.com. Replays will be available for on-demand listening shortly after the completion of the presentation. About agilon health agilon health is the trusted partner empowering physicia

      4/4/25 4:15:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • agilon health Sets Date to Report First Quarter 2025 Financial Results

      agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 095319. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the ca

      3/25/25 4:05:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    Financials

    Live finance-specific insights

    See more
    • agilon health Sets Date to Report First Quarter 2025 Financial Results

      agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 095319. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the ca

      3/25/25 4:05:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • agilon health Sets Date to Report Fourth Quarter and Full Year 2024 Financial Results

      agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will release its financial results for the fourth quarter and full year 2024 after the market closes on Tuesday February 25, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 599648. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A

      2/10/25 4:01:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • agilon health Reports Third Quarter 2024 Results

      Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses Adjusted full year guidance reflects Q3 results and updated Q4 cost trends agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. "Our full-risk model enables primary care physicians to deliver high-quality c

      11/7/24 4:00:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    SEC Filings

    See more
    • agilon health inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - agilon health, inc. (0001831097) (Filer)

      5/30/25 4:43:53 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.

      SCHEDULE 13G/A - agilon health, inc. (0001831097) (Subject)

      5/13/25 11:44:13 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.

      SCHEDULE 13G/A - agilon health, inc. (0001831097) (Subject)

      5/12/25 10:44:45 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Schwaneke Jeffrey A. covered exercise/tax liability with 9,331 shares, decreasing direct ownership by 0.83% to 1,121,221 units (SEC Form 4)

      4 - agilon health, inc. (0001831097) (Issuer)

      5/30/25 8:11:00 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Director Mckenzie Diana was granted 78,724 shares, increasing direct ownership by 134% to 137,543 units (SEC Form 4)

      4 - agilon health, inc. (0001831097) (Issuer)

      5/30/25 7:39:34 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Director Wulf John William was granted 78,724 shares, increasing direct ownership by 38% to 284,857 units (SEC Form 4)

      4 - agilon health, inc. (0001831097) (Issuer)

      5/30/25 6:32:44 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Schwaneke Jeffrey A. bought $250,206 worth of shares (22,300 units at $11.22) and was granted 428,922 shares, increasing direct ownership by 61% to 1,130,552 units (SEC Form 4)

      4/A - agilon health, inc. (0001831097) (Issuer)

      4/3/25 7:40:25 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • CEO & President Sell Steven covered exercise/tax liability with 15,563 shares and bought 42,426 shares, increasing direct ownership by 8% to 355,310 units (SEC Form 4)

      4 - agilon health, inc. (0001831097) (Issuer)

      3/18/25 6:42:37 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Chief Markets Officer Shaker Benjamin bought 11,786 shares and covered exercise/tax liability with 4,143 shares, increasing direct ownership by 2% to 457,058 units (SEC Form 4)

      4 - agilon health, inc. (0001831097) (Issuer)

      3/18/25 6:41:48 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by agilon health inc.

      SC 13G/A - agilon health, inc. (0001831097) (Subject)

      11/13/24 12:49:26 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by agilon health inc.

      SC 13G/A - agilon health, inc. (0001831097) (Subject)

      11/8/24 10:52:39 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by agilon health inc.

      SC 13G/A - agilon health, inc. (0001831097) (Subject)

      11/6/24 4:47:14 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    Leadership Updates

    Live Leadership Updates

    See more
    • agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

      Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon's Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agilon in 2022, Dr. Rao held several roles in value-based care, including nearly a d

      7/10/24 8:00:00 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • agilon health Names Jeff Schwaneke New Chief Financial Officer

      agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period. Schwaneke was most recently executive vice president, Health Care Enterprises,

      6/5/24 8:00:00 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • agilon health, inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL) investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to

      5/13/24 6:31:12 PM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care

    $AGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Agilon Health upgraded by Citigroup with a new price target

      Citigroup upgraded Agilon Health from Neutral to Buy and set a new price target of $5.00

      4/25/25 8:23:09 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Agilon Health upgraded by Bernstein with a new price target

      Bernstein upgraded Agilon Health from Mkt Perform to Outperform and set a new price target of $8.50

      4/8/25 9:06:22 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care
    • Agilon Health upgraded by Citigroup with a new price target

      Citigroup upgraded Agilon Health from Sell to Neutral and set a new price target of $2.25 from $1.75 previously

      1/10/25 7:25:30 AM ET
      $AGL
      Misc Health and Biotechnology Services
      Health Care